Latest Strategic Capital Raising News

Identitii Limited has sold its remaining Payble shares for $1.6 million, channeling the funds into expanding its BNDRY platform through a strategic partnership with Cherryhub targeting Australia's clubs and pubs sector.

Evolution Energy Minerals has unveiled a strategic update on its development-ready Tanzanian graphite project, announcing a $1.45 million renounceable rights issue to accelerate project development and capitalize on binding offtake agreements.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

DigitalX Limited posted a larger loss for FY25 despite an 18% revenue increase, driven by digital asset appreciation and a bold Bitcoin accumulation strategy.

Aspermont Limited invites existing shareholders to participate in a $1.25 million Share Purchase Plan at a premium price, supporting its pivot to data-driven intelligence services and a strategic Rio Tinto partnership.

IMEXHS reported a steady first half of FY25 with revenue up 4% and annualised recurring revenue climbing 11%, driven by strong adoption of its Aquila+ radiology platform and strategic capital raising.

DorsaVi Limited reported a 13.9% revenue decline and a 21.7% rise in net loss for FY25, while securing over $3 million in capital to fuel new technology ventures.

Simble Solutions Limited reported a 21.3% revenue decline and a $646,578 net loss for H1 2025, while raising $807,375 to fund strategic growth in renewable energy and AI integration.

GemLife Communities Group reported a 16% dip in net profit for H1 2025 but bolstered its balance sheet with a $750 million IPO and a strategic $220 million acquisition.

Omni Bridgeway Limited has reported a robust FY25 with full debt repayment, strong portfolio returns, and strategic capital raises positioning it as a leader in legal finance. The company’s disciplined cost management and validated fair value approach underpin its confident outlook for FY26.

Flight Centre Travel Group has priced a A$450 million convertible notes offering with a 2.5% coupon and a 37.5% conversion premium, while repurchasing A$225 million of existing notes to streamline its capital structure.

Optiscan Imaging Ltd has launched a fully underwritten $17.75 million entitlement offer to fund clinical trials and regulatory clearances for its medical devices, marking a pivotal step in its transition to a commercial medical device manufacturer.